REUTERS – Why Europe’s drug shortages may get worse

8 February 2023

When Ignasi Biosca-Reig heard there were shortages of amoxicillin in […]

EURACTIV – Adjust prices to save drugs, generics industry tells EU

6 February 2023

The generics industry is urging EU and national governments to […]

POLITICO – Everything you wanted to know about the EU’s pharma reform (but were too afraid to ask)

17 January 2023

Can the European Union bring eye-wateringly expensive medicines to the […]

PHARMA BOARDROOM – Inflation’s Impact on Medicine Supply: Challenges for the Off-Patent Industry

19 October 2022

Victor Mendonça, chair of the Generic Market Access Committee at […]

MANUFACTURING CHEMIST – EU supply chain regulation: what will it mean for companies attending CPHI?

17 October 2022

Ahead of her session on “Manufacturing Excellence” at CPHI Frankfurt […]

PHARMACEUTICAL TECHNOLOGY – Inflation drives pharma manufacturing to focus on sustainability

11 October 2022

Inflation is at an all-time high, opening an opportunity for […]

REUTERS – Europe’s generic drugmakers say they may cut output due to energy bills

28 September 2022

The generic drug industry lobby group Medicines for Europe on […]

CORREO FARMACEUTICO – Elisabeth Stampa Stampa, Presidenta de Medicines for Europe y Consejera Delegata de Medichem

31 March 2022

REGULATORY FOCUS – New reports address generics pricing, innovation in the EU

2 December 2021

Open

Open letter: Urgent call to amend the Temporary State Aid Framework to achieve the Recovery and Resiliency Facility objectives

17 November 2021